[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
Oganov
R G
RG
Lepakhin
V K
VK
Fitilev
S B
SB
Levin
A M
AM
Titarova
Yu Yu
YY
Sytchev
E N
EN
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001262:Atenolol / Q000008:administration & dosage / Q000627:therapeutic use; D015992:Body Mass Index; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D048909:Diabetes Complications; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D012426:Russia / Q000453:epidemiology; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D001262:Atenolol; D014700:Verapamil; D001241:Aspirin